Context-driven changes in l-DOPA-induced behaviours in the 6-OHDA lesioned rat

Context-driven changes in l-DOPA-induced behaviours in the 6-OHDA lesioned rat

Both contralateral rotational behaviour and dyskinetic abnormal involuntary movements (AIMs) are induced by the administration of l-DOPA in the unilateral 6-OHDA lesioned rat model of Parkinson's disease. Since rotational responses can be conditioned to environmental cues we have investigated t...

Full description

Bibliographic Details
Main Authors:	E.L. Lane, C.S. Daly, G.A. Smith, S.B. Dunnett
Format:	Article
Language:	English
Published:	Elsevier 2011-04-01
Series:	Neurobiology of Disease
Subjects:	Context-dependent conditioning Context-specific sensitisation l-DOPA-induced dyskinesia Abnormal involuntary movements Rotation
Online Access:	http://www.sciencedirect.com/science/article/pii/S0969996111000118

Similar Items

RGS4 is involved in the generation of abnormal involuntary movements in the unilateral 6-OHDA-lesioned rat model of Parkinson's disease
by: Wai Kin D. Ko, et al.
Published: (2014-10-01)

Effects of L-dopa priming on cortical high beta and high gamma oscillatory activity in a rodent model of Parkinson's disease
by: Kristin B. Dupre, et al.
Published: (2016-02-01)

Targeting the cannabinoid receptor CB2 in a mouse model of l-dopa induced dyskinesia
by: Peggy Rentsch, et al.
Published: (2020-02-01)

Spontaneous locomotor activity and L-DOPA-induced dyskinesia are not linked in 6-OHDA parkinsonian rats
by: Stefania eSgroi, et al.
Published: (2014-10-01)

Combination Treatment of Icariin and L-DOPA Against 6-OHDA-Lesioned Dopamine Neurotoxicity
by: Di-Sheng Lu, et al.
Published: (2018-05-01)

Corrigendum: Combination Treatment of Icariin and L-DOPA Against 6-OHDA-Lesioned Dopamine Neurotoxicity
by: Di-Sheng Lu, et al.
Published: (2020-10-01)

Early L-dopa, but not pramipexole, restores basal ganglia activity in partially 6-OHDA-lesioned rats
by: C. Marin, et al.
Published: (2014-04-01)

Correlación entre la expresión del receptor dopaminérgico D2 y presencia de movimientos involuntarios anormales (MIA) en un modelo de disquinesia en ratas Wistar hemiparkinsonizadas
by: P.A. Caro Aponte, et al.
Published: (2021-04-01)

Prevalence of spontaneous dyskinesia in first episode, drug naive schizophrenia, and its relation to the positive and negative symptoms of schizophrenia
by: Samrat Singh Bhandari, et al.
Published: (2017-06-01)

Nicotine-mediated improvement in l-dopa-induced dyskinesias in MPTP-lesioned monkeys is dependent on dopamine nerve terminal function
by: Maryka Quik, et al.
Published: (2013-02-01)

The importance of A9 dopaminergic neurons in mediating the functional benefits of fetal ventral mesencephalon transplants and levodopa-induced dyskinesias
by: Wei-Li Kuan, et al.
Published: (2007-03-01)

Time dependent degeneration of the nigrostriatal tract in mice with 6-OHDA lesioned medial forebrain bundle and the effect of activin A on l-Dopa induced dyskinesia
by: Peggy Rentsch, et al.
Published: (2019-02-01)

Riluzole Administration to Rats with Levodopa-Induced Dyskinesia Leads to Loss of DNA Methylation in Neuronal Genes
by: Luca Pagliaroli, et al.
Published: (2021-06-01)

Abnormal cortical facilitation and L-dopa-induced dyskinesia in Parkinson's disease
by: Andrea Guerra, et al.
Published: (2019-11-01)

Human COMT over-expression confers a heightened susceptibility to dyskinesia in mice
by: Oscar Solís, et al.
Published: (2017-06-01)

Neuroanatomical and Microglial Alterations in the Striatum of Levodopa-Treated, Dyskinetic Hemi-Parkinsonian Rats
by: Edward J. R. Fletcher, et al.
Published: (2020-09-01)

On dopamine neurons : nerve fiber outgrowth and L-DOPA effects
by: af Bjerkén, Sara
Published: (2008)

Nitric oxide synthase inhibition decreases l-DOPA-induced dyskinesia and the expression of striatal molecular markers in Pitx3−/− aphakia mice
by: Oscar Solís, et al.
Published: (2015-01-01)

Beneficial effects of the phytocannabinoid Δ9-THCV in L-DOPA-induced dyskinesia in Parkinson's disease
by: Isabel Espadas, et al.
Published: (2020-07-01)

Systemic Inflammation Increases the Susceptibility to Levodopa-Induced Dyskinesia in 6-OHDA Lesioned Rats by Targeting the NR2B-Medicated PKC/MEK/ERK Pathway
by: Aijuan Yan, et al.
Published: (2021-02-01)

Effects of a combination treatment of KD5040 and L-dopa in a mouse model of Parkinson’s disease
by: Sora Ahn, et al.
Published: (2017-04-01)

Circuit Mechanisms of L-DOPA-Induced Dyskinesia (LID)
by: Kai Yang, et al.
Published: (2021-03-01)

An exploratory study from eastern India on neurological soft signs and spontaneous movement disorders in schizophrenia spectrum disorders
by: Shyamanta Das, et al.
Published: (2019-01-01)

Impact of dopamine to serotonin cell ratio in transplants on behavioral recovery and L-DOPA-induced dyskinesia
by: Joanna García, et al.
Published: (2011-09-01)

Pathophysiological Mechanisms and Experimental Pharmacotherapy for L-Dopa-Induced Dyskinesia
by: Fabbrini A, et al.
Published: (2021-04-01)

Abnormal structure-specific peptide transmission and processing in a primate model of Parkinson's disease and l-DOPA-induced dyskinesia
by: Mathieu Bourdenx, et al.
Published: (2014-02-01)

Immediate-early gene expression in structures outside the basal ganglia is associated to l-DOPA-induced dyskinesia
by: Matthieu F. Bastide, et al.
Published: (2014-02-01)

Enhanced histamine H2 excitation of striatal cholinergic interneurons in l-DOPA-induced dyskinesia
by: Sean Austin O. Lim, et al.
Published: (2015-04-01)

Dysfunction in the nigrostriatal system : effects of L-DOPA and GDNF
by: Nevalainen, Nina
Published: (2013)

The Rodent Models of Dyskinesia and Their Behavioral Assessment
by: Qiwei Peng, et al.
Published: (2019-10-01)

5-Hydroxy-tryptophan for the treatment of l-DOPA-induced dyskinesia in the rat Parkinson's disease model
by: Elisabetta Tronci, et al.
Published: (2013-12-01)

Gadd45β ameliorates L-DOPA-induced dyskinesia in a Parkinson's disease mouse model
by: Hye-Yeon Park, et al.
Published: (2016-05-01)

Effect of a selective glutamate antagonist on l-dopa-induced dyskinesias in drug-naive parkinsonian monkeys
by: Abdallah Hadj Tahar, et al.
Published: (2004-03-01)

Pharmacogenetics of antipsychotic-induced movement disorders as a resource for better understanding Parkinson's disease modifier genes
by: Lior eGreenbaum, et al.
Published: (2015-02-01)

Role of the atypical vesicular glutamate transporter VGLUT3 in l-DOPA-induced dyskinesia
by: Giuseppe Gangarossa, et al.
Published: (2016-03-01)

Striatal signaling in L-DOPA-induced dyskinesia: common mechanisms with drug abuse and long term memory involving D1 dopamine receptor stimulation
by: Mario Gustavo Murer, et al.
Published: (2011-08-01)

Transcriptome analysis in a rat model of l-DOPA-induced dyskinesia
by: Christine Konradi, et al.
Published: (2004-11-01)

Comparison of rating scales used to evaluate l-DOPA-induced dyskinesia in the 6-OHDA lesioned rat
by: Ludivine S. Breger, et al.
Published: (2013-02-01)

Intrastriatal inhibition of aromatic amino acid decarboxylase prevents l-DOPA-induced dyskinesia: A bilateral reverse in vivo microdialysis study in 6-hydroxydopamine lesioned rats
by: Kerstin Buck, et al.
Published: (2008-02-01)

Excessive sensitivity to uncertain visual input in L-dopa induced dyskinesias in Parkinson’s disease: further implications for cerebellar involvement
by: James eStevenson, et al.
Published: (2014-02-01)